Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

47 trials with published results (18%)

Research Maturity

135 completed trials (52% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

7.7%

20 terminated out of 260 trials

Success Rate

87.1%

+0.5% vs benchmark

Late-Stage Pipeline

5%

12 trials in Phase 3/4

Results Transparency

35%

47 of 135 completed with results

Key Signals

47 with results87% success20 terminated

Data Visualizations

Phase Distribution

178Total
Not Applicable (98)
Early P 1 (8)
P 1 (24)
P 2 (36)
P 3 (8)
P 4 (4)

Trial Status

Completed135
Recruiting49
Unknown21
Terminated20
Active Not Recruiting20
Withdrawn11

Trial Success Rate

87.1%

Benchmark: 86.6%

Based on 135 completed trials

Clinical Trials (260)

Showing 20 of 20 trials
NCT06439979Not ApplicableRecruiting

Rural Adult and Youth Sun Protection Study

NCT00591500Active Not Recruiting

A Model for Genetic Susceptibility: Melanoma

NCT05715255Not ApplicableActive Not Recruiting

Adaptive Symptom Self-Management Immunotherapy Study

NCT07177638Not ApplicableActive Not RecruitingPrimary

A Community-based Educational Initiative to Raise Awareness of Melanoma and Other Skin Cancers.

NCT05634252Phase 3Active Not RecruitingPrimary

Undergraduate Skin Cancer Prevention Trial

NCT07042243Not ApplicableRecruiting

The Florida ASCENT Study

NCT04122456Not ApplicableRecruitingPrimary

DNA Repair Activity in the Skin of Day and Night Shift Workers

NCT06615635Not ApplicableRecruiting

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients

NCT01535963CompletedPrimary

Patient Satisfaction in Cutaneous Surgery

NCT07247123Not ApplicableRecruitingPrimary

Developing and Testing the Effectiveness of a Skin Cancer Self-Detection Educational Program

NCT02012699Recruiting

Integrated Cancer Repository for Cancer Research

NCT05520099Active Not Recruiting

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)

NCT07327489Recruiting

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

NCT07670403CompletedPrimary

Digital Phenotyping of Psychological Distress in Skin Cancer Patients

NCT07406022RecruitingPrimary

Optical Characterization and Multi-modality, Multi-scale Modeling of Human Skin Applied to Cancer Diagnosis.

NCT06298734Not ApplicableRecruiting

High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial

NCT04068155Not ApplicableRecruitingPrimary

Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors

NCT04534127Not ApplicableRecruitingPrimary

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

NCT05313711CompletedPrimary

Photographic Rhinometry Following Derm/Mohs Surgery for Skin Cancers

NCT07286318Early Phase 1RecruitingPrimary

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

Scroll to load more

Research Network

Activity Timeline